News & Events
Nanopharm News & Events
Nanopharm is continually expanding its specialized nasal and inhaled drug delivery development capabilities and participates in numerous events within the OINDP pharmaceutical community. Learn more about the latest news and events at Nanopharm.
18 July 2025
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
The acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities strengthens Aptar Pharma’s service portfolio to meet growing demand for early-phase clinical trial support and innovation.
Filter Resources By
01 Apr 2022
Aptar Pharma, drug delivery, Nasal
01 Apr 2022
drug formulation, formulation and development, Nasal
09 Dec 2021
Biologics Characterization, cGMP, Drug Development, Nanopharm, OINDP, Particle Engineering
03 Nov 2021
Aerodynamic, Antigen, Dry Powder, GLA, Human Papillomavirus, Inhalation, Nanopharm, Performance, Vaccine
21 Jul 2021
Drug Development, Intranasal Spray, Leyden Labs, Nanopharm, OINDP, Respiratory Viruses
11 Jan 2021
drug delivery, Inhalation, Low GWP, Nanopharm, pMDIs, Propellants, Valve and Actuator
04 Jan 2021
Container Closure System, Nanopharm, pMDIs, Salmeterol Xinafoate, Valve Types
01 Jan 2021
DPI, drug delivery, Dry powder inhaler, Inhalation, Particle Size, respiratory diseases
09 Jan 2020
DPI, Drug Absorption, Dry powder inhaler, Generic, In Silico, Nanopharm, Tiotropium
08 Jan 2020
Aerodynamic Performance, COPD, FPM, High Resistance, Inhaler, MMAD
